electrospray ionization mass spectrometry
Mayo Group Uses Abbott Plex-ID System to Identify TB Complex, Drug Resistance Markers from Culture
Premium
A Mayo Clinic research group that previously evaluated Abbott's PCR-electrospray ionization mass spectrometry platform to broadly identify fungal infections has now published research demonstrating the system's ability to identify Mycobacterium species and M.
Study Vets Abbott Plex-ID Platform as Tool for Broad Fungal ID Directly from Clinical Specimens
Premium
Researchers from the Mayo Clinic have demonstrated that Abbott's Plex-ID broad fungal assay is as good or in some cases better than culture-based methods for identifying fungal infections to the species level directly from respiratory specimens without prior knowledge of the offending orga
Abbott Developing Next-Gen Version of Plex-ID Platform as More Studies Back Clinical Potential
Premium
Scientists from Abbott and collaborating academic institutions have recently published a pair of studies demonstrating the ability of Abbott's Plex-ID platform to detect and identify in human samples a wide array of clinically relevant infectious organisms not picked up using mor
Abbott Lyme Disease Assay, Sample-Prep Method for Plex-ID Underscores Platform's MDx Potential
Premium
NEWPORT BEACH, Calif. – Scientists at Abbott subsidiary Ibis Biosciences have developed an assay to detect and genotype Borrelia burgdorferi, the bacterium responsible for causing Lyme disease in humans, using Abbott's Plex-ID microbial identification system.
PerkinElmer Sues Agilent for Infringing Mass Spec Patents
NEW YORK (GenomeWeb News) – PerkinElmer is suing Agilent for infringement of two patents covering mass spectrometry technology.
Mar 12, 2012
Waters, Protea Ink Co-marketing Pact
Feb 23, 2012
Jun 6, 2011